Target intelligence / Profile preview

Intraflagellar transport protein 172 (IFT172)

Target
IFT172
Molecular classification
Structural protein, Transport-associated protein, Ciliary protein (component of intraflagellar transport complex, IFT-B), Other (does not fall under receptor, ion channel, enzyme, etc.)
01

Overview

IFT172 is a large membrane-associated protein (~200 kDa) essential for the formation and maintenance of primary cilia, functioning as a key component of the intraflagellar transport (IFT) particle complex (specifically, the IFT-B subcomplex)[1][2][3][4]. It has a distinctive structure with WD40 repeats and degenerate WAA repeats that facilitate transient protein interactions and membrane remodeling[1][2][4]. IFT172’s conformational flexibility allows it to interact with ciliary membranes and form vesicles, acting as a modulatory cargo adapter within IFT complexes[1][2][4]. Its roles include mediating the bidirectional transport of proteins within cilia—critical for ciliogenesis—and assisting in the transition between anterograde and retrograde transport at the ciliary tip[1][2][3][4]. Dysfunction and mutations of IFT172 are linked to multiple ciliopathies, a group of genetic disorders characterized by abnormal cilia structure and function, resulting in complex clinical phenotypes ranging from kidney disease and obesity to intellectual disability and retinal degeneration[1][2].

Other names
Selective LIM domain binding protein (SLB)IFT172 proteinCiliopathy protein 172 (contextual, less common)
02

Mechanism of action

Not applicable; as no drugs directly target IFT172, no mechanisms of action are described

03

Biological functions

Cilia formation and maintenance (ciliogenesis)Regulation of intraflagellar transport (anterograde and retrograde transport within cilia/flagella)Membrane remodeling (binds and forms vesicles from lipid membranes)Patterning of the developing brain (via ciliary function)Assembly of IFT-B2 complex in cilia
04

Disease associations

Ciliopathies (e.g., Bardet-Biedl syndrome, Mainzer-Saldino syndrome)RetinopathyCongenital kidney diseaseIntellectual disabilityPolycystic kidney diseaseObesity (as part of Bardet-Biedl syndrome)Cancer (as implicated through ciliary dysfunction)
05

Biomarkers

Mutations in IFT172 gene (for genetic diagnosis of ciliopathies such as Bardet-Biedl syndrome, Mainzer-Saldino syndrome)IFT172 protein expression (potential research biomarker in ciliary disorders)

Beyond the preview

Go deeper on Intraflagellar transport protein 172 (IFT172).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intraflagellar transport protein 172 (IFT172).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call